Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Latest IVD Innovations at EUROMEDLAB 2022

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022

Mindray (Shenzhen, China) displayed its latest laboratory innovations at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, EUROMEDLAB 2022, in Munich, Germany. More...

EUROMEDLAB is the most influential platform in Europe where new ideas and technologies in laboratory diagnostics are shared and showcased. Mindray’s wide range of IVD products attracted customers from Europe and other parts of the world.

At EUROMEDLAB 2022, Mindray displayed the new MC-80 automated digital cell morphology analyzer that is taking digital morphology analysis to the next level by delivering clearer images which are able to capture abnormalities in more detail. With advanced algorithms, the analyzer enables better identification of different cells with high throughput, resulting in greater productivity. Its high-performance objective and advanced image sensor offer ultra resolution images to reappear the real view under the microscope. The MC-80 has an industry-leading throughput of 60 slides per hour and features a solid rock hyper-stable anti-shake system. Aerospace materials and cutting-edge high-frequency exposure algorithm are integrated to eliminate blurred images.

Mindray also demonstrated the new CAL 8000 New Generation Cellular Analysis Line which marks the company’s expertise and innovative power in hematology area for large-scale laboratories. It has higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray’s new MC-80 digital cell morphology analyzer, the CAL 8000 is taking hematology analysis automation to the next level. The touch screen is the “brain” of CAL 8000. It optimizes the distribution of workload between each analyzer unit and decides which sample requires a blood smear. It displays the status of each analyzer or SC-120 installed on CAL 8000 as well as the volume of balance reagent. This intuitive software can tell the users all necessary information of CAL 8000 at any given time. Consequently, users spend less time operating CAL 8000 and can arrange their working schedule better. Additionally, Mindray exhibited its M6000 laboratory automation system which can empower ultra high volume laboratories with high processing speed, less hands-on time, great cost efficiency and standardized analytical quality.

Related Links:
Mindray 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Pathology

view channel
Image: The new methyl-copying PCR method preserves DNA methylation patterns during amplification (Photo courtesy of Syndex Bio)

Novel mcPCR Technology to Transform Testing of Clinical Samples

DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.